Pancreatic Progenitors and Organoids as a Prerequisite to Model Pancreatic Diseases and Cancer
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are characterized by their unique capacity to stepwise differentiate towards any particular cell type in an adult organism. Pluripotent stem cells provide a beneficial platform to model hereditary diseases and even cancer develop...
Main Authors: | Meike Hohwieler, Martin Müller, Pierre-Olivier Frappart, Sandra Heller |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2019/9301382 |
Similar Items
-
Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine
by: Pierre-Olivier Frappart, et al.
Published: (2020-09-01) -
Organoids to study and stop pancreatic cancer
by: David Tuveson
Published: (2016-01-01) -
Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks
by: Lukas Perkhofer, et al.
Published: (2019-01-01) -
Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids
by: Palzer J, et al.
Published: (2021-04-01) -
Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease
by: L. Schulte, et al.
Published: (2019-01-01)